Author:
Moreno Lucas, ,Pearson Andrew D. J.,Paoletti Xavier,Jimenez Irene,Geoerger Birgit,Kearns Pamela R.,Zwaan C. Michel,Doz Francois,Baruchel Andre,Vormoor Josef,Casanova Michela,Pfister Stefan M.,Morland Bruce,Vassal Gilles
Publisher
Springer Science and Business Media LLC
Reference111 articles.
1. Pritchard-Jones, K. & Sullivan, R. Children with cancer: driving the global agenda. Lancet Oncol. 14, 189–191 (2013).
2. Skinner, R., Wallace, W. H. B., Levitt, G. A. & UK Children's Cancer Study Group (UKCCSG) Late Effects Group (LEG). Long-term follow-up of people who have survived cancer during childhood. Lancet Oncol. 7, 489–498 (2006).
3. Di Martino, S. et al. Overview of FDA-approved anti cancer drugs used for targeted therapy. World Cancer Res. J. 2, e553 (2015).
4. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
5. Smith, M. et al. Conduct of phase I trials in children with cancer. J. Clin. Oncol. 16, 966–978 (1998).
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献